Published in Gene Therapy Weekly, April 13th, 2000
The results from microarray (gene chip) studies reported at the American Society for Experimental Neurotherapeutics, held in Washington, DC, during March 2000, might provide the basis for developing new treatments for acute and chronic spinal cord injury.
"Methylprednisolone, an anti-inflammatory steroid, has been the standard of care for patients with acute spinal cord injury. We are now...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.